A total of 4 analyst ratings have been received for Sage Therapeutics, with the consensus rating being Neutral. The average one-year price target stands at $9.5, suggesting a potential 21.95% upside.

Journalist Sage Steele reccently got engaged. The 52-year-old former ESPN host was proposed to by her fiancé on the beaches ...

Oneka Wilson’s 100m hurdles win, Auhmad Robinson’s 44.99 anchor, and more highlights from Day 3 of Penn Relays 2025 at Franklin Field, Philadelphia.